The Complete Ingredient Breakdown
Honeybush
The bottom line
Bottom Line
What is Honeybush?
Honeybush tea is made from Cyclopia, a genus of 23 shrub species endemic to South Africa's Western and Eastern Cape, and the traditional "fermentation" step significantly lowers mangiferin in all four species tested. That one processing choice explains why the red tea on the shelf and the extracts used in laboratory studies are chemically different products.
Cyclopia belongs to the legume family (Fabaceae, tribe Podalyrieae). The plants are woody shrubs with trifoliate leaves and yellow, honey-scented flowers, and they grow in fynbos on nutrient-poor mountain and coastal soils, where wild populations at all but one site studied drew 70% to 100% of their nitrogen from root-nodule bacteria (Spriggs and colleagues, Tree Physiology, 2008). A handful of species carry most of the commercial weight. Cyclopia intermedia (bergtee, "mountain tea") is still mostly cut from wild stands. C. subternata (vleitee, "marsh tea"), C. longifolia and C. genistoides make up the cultivated crop, and C. genistoides and C. maculata are the species most often turned into extracts. C. sessiliflora and C. plicata are traded in smaller volumes.
The tea has a written history. A 1705 European taxonomic record is the earliest reference; Carl Thunberg recorded the name "honigtee" during his Cape travels in the 1770s; and in 1830 Bowie described a decoction used as a restorative and an expectorant for chronic catarrh and pulmonary tuberculosis (all three dates as compiled by Joubert and colleagues, South African Journal of Botany, 2011). Processed C. intermedia sold for under 2 cents a kilogram in the 1930s. The first export, 500 kg, went to Japan in October 1993, and the first German shipment, 4 tonnes, followed on May 8, 1995. Today honeybush is sold as loose or bagged tea (oxidized "red" or unoxidized "green"), as iced-tea and food-ingredient extracts, and in a small number of capsule and drink supplements, of which only one, as far as we could find, has a published human trial.
Common Names
Honeybush, honeybush tea, heuningbos (Afrikaans), honigtee (Thunberg's record), bergtee (C. intermedia), vleitee (C. subternata), red honeybush (used in some papers for C. genistoides). The Agricultural Research Council trademarked "Cape Herbal Tea," "Cape Tea," "Cape Honeybush Tea" and "Cape Fynbos Tea" in 2006. "Honeybush Tea" is one of 105 South African names protected as geographical indications under the 2016 Economic Partnership Agreement with the European Union. Honeybush is a different plant from rooibos (Aspalathus linearis, another Cape legume), although the two are often blended and shelved together.
Primary Active Compounds
The defining compounds are two C-glucosyl xanthones, mangiferin and isomangiferin, and a set of flavanone glycosides led by hesperidin, with eriocitrin and narirutin. In hot-water extracts of unfermented plant material, mangiferin measured 9.55 g per 100 g of extract solids in C. genistoides, 4.67 g in C. sessiliflora, 4.35 g in C. intermedia and 2.73 g in C. subternata; hesperidin ran 0.62 to 0.74 g per 100 g across the same four species (Joubert and colleagues, Journal of Agricultural and Food Chemistry, 2008, as tabulated in the 2011 review). Benzophenones (iriflophenone and maclurin glucosides), the dihydrochalcone phloretin-3',5'-di-C-glucoside (prominent in C. subternata), the flavones scolymoside, vicenin-2 and luteolin, the isoflavones formononetin and calycosin, three coumestans and the sugar alcohol pinitol complete the profile. A 2019 survey of 82 samples from 15 of the 23 species (Stander and colleagues, Molecules) found mangiferin and isomangiferin to be the main compounds in most samples, but two species contained neither.
Key Note
"Fermented" means two unrelated things on honeybush labels and in honeybush research. In the tea trade it is a heat-driven oxidation of moist, shredded shoots: industry practice is 70 °C for 60 hours for C. intermedia and 80 to 85 °C for 18 to 24 hours for the other species. In the only randomized oral trial, "fermented honeybush extract" (HU-018) meant a water extract fermented by lactic acid bacteria at 37 °C for 48 hours with milk powder and lactose, then spray-dried onto dextrin. Neither preparation tells you anything reliable about the other.
Honeybush is a pleasant, low-tannin herbal tea with a large cell and animal literature, one company-coauthored skin trial in Korean adults, and no controlled human evidence for the menopause and blood sugar uses it is most often sold for.
Scan any Honeybush product in seconds with the free NutrientWise app: App Store · Google Play
What the Label Won't Tell You
Most honeybush is still cut from mountainsides, and its main health claims are untested in people. The South African Honeybush Tea Association's 2022 to 2023 industry statistics put the wild-harvested share at 53%, and 85% of that wild crop is a single species, Cyclopia intermedia. A Rhodes University study of wild C. intermedia recorded the death of 45% of plants over seven years in one population under unregulated harvesting and concluded that a three-year cutting cycle is unsustainable. On June 24, 2022, South Africa gazetted a Biodiversity Management Plan for C. intermedia and C. subternata because both are declining in the wild. The only randomized, placebo-controlled oral trial we located tested wrinkles, not menopause or blood sugar: 120 Korean adults were randomized to a bacterially fermented extract, HU-018, or placebo for 12 weeks, and four of the paper's eight authors were affiliated with its maker, Huons. We found no controlled human trial of honeybush for menopausal symptoms or glucose control.
Primary Functions & Benefits
Honeybush is sold first as a beverage and second as a health ingredient. The health claims attached to it fall into five groups, and they rest on very different amounts of evidence.
Skin aging, the one oral trial
Choi and colleagues (Journal of Cosmetic and Laser Therapy, 2018) randomized 120 Korean adults with crow's feet wrinkles to 400 mg a day of HU-018, 800 mg a day, or placebo for 12 weeks. HU-018 is a hot-water extract of C. intermedia fermented with lactic acid bacteria, not ordinary honeybush tea. The abstract reports that global wrinkle grade, skin hydration and elasticity improved significantly in both extract groups compared with placebo, that transepidermal water loss fell in both, and that no adverse effects occurred. It does not report how many participants completed each arm or the size of the differences. Four of the eight authors listed affiliations with Huons Co., the Korean company that developed HU-018 and sells it as the Innerset Honeybush line. We found no independent replication.
Skin, applied topically
Gerber and colleagues (Pharmacognosy Magazine, 2015) gave 16 healthy women aged 40 to 65 creams containing 2% C. maculata or 2% C. genistoides extract on the forearm for 2 weeks. Both creams improved skin smoothness, C. maculata reduced scaliness more than placebo, and neither improved skin hydration compared with placebo. In skin penetration tests the creams delivered extremely low concentrations of mangiferin and hesperidin, and both formulations were unstable over 3 months. Other skin data are from cells and hairless mice: Petrova and colleagues (2011) applied honeybush extracts to SKH-1 mice before 10 days of ultraviolet B exposure at 180 mJ/cm² and saw less redness, swelling and epidermal thickening.
Blood sugar
Every glucose result is from animals or test tubes. In streptozotocin-diabetic rats, a single 50 mg/kg dose of a hot-water extract of fermented honeybush (equal to 2.90 mg of mangiferin) lowered fasting glucose for 3 to 6 hours, and 12 weeks of the extract in drinking fluid improved glucose tolerance and lowered total cholesterol in obese insulin-resistant rats (Muller and colleagues, as summarized by Ajuwon and colleagues, Molecules, 2018). Chellan and colleagues (Planta Medica, 2014) reported that pretreatment with an unfermented C. maculata extract reduced the glucose-tolerance curve and fasting glucose in streptozotocin rats and preserved beta-cell area. In vitro, a xanthone-enriched C. genistoides fraction inhibited alpha-glucosidase with an IC50 of 43.3 µg/mL (Miller and colleagues, Food and Function, 2020). No trial in people with prediabetes or diabetes has been published.
Menopause and estrogen activity
A 2004 chemistry paper described honeybush as "becoming well-known for its effectiveness in alleviating menopausal symptoms in women" (Kamara and colleagues, Journal of Agricultural and Food Chemistry), a claim that no controlled trial in the record we searched has tested. The supporting work is receptor pharmacology. Methanol extracts of C. genistoides acted mainly through estrogen receptor beta, and extracts from one harvest bound both receptor subtypes (Verhoog and colleagues, 2007). Visser and colleagues (PLoS One, 2013) tested three extracts, P104, SM6Met (a sequential methanol extract of C. subternata) and a cup-of-tea preparation: each acted as an estrogen receptor alpha antagonist and beta agonist when the receptors were expressed separately, but only as an agonist when both were present, and none caused uterine growth in immature rats. Of the three, only the cup-of-tea preparation resembles anything a shopper can buy. No study has measured hot flashes, sleep, bone density or vaginal symptoms in women drinking honeybush or taking its extracts.
Weight, cancer and allergy claims
A crude polyphenol-enriched fraction of C. intermedia inhibited body weight gain in obese diabetic female db/db mice, and a 2023 follow-up by the same group found it raised uncoupling protein 1 in brown fat 3.4-fold (Jack and colleagues, International Journal of Molecular Sciences). Topical honeybush fractions inhibited chemically promoted skin tumors in ICR mice by 84.2% (processed) and 90% (unprocessed) (Marnewick and colleagues, Cancer Letters, 2005), and unfermented C. intermedia tea as drinking fluid cut esophageal papilloma multiplicity in rats by 45.5% (Sissing and colleagues, Nutrition and Cancer, 2011). Extracts of two honeybush species suppressed anaphylactic temperature drop in an ovalbumin-inhaled mouse model, although the same extracts raised the mice's allergen-specific IgE antibodies (Shimbo and colleagues, 2024). None of these outcomes has been tested in humans, and the doses, routes and fractions do not translate to a cup of tea.
Traditional use
Bowie's 1830 account records honeybush as a restorative and an expectorant for chronic catarrh and pulmonary tuberculosis. Later reviews also mention appetite stimulation and increased breast-milk production, described as anecdotal. Neither use has been studied clinically.
Forms & Standardization
Honeybush reaches buyers in four forms, and their chemistry differs more than the shared name suggests.
Fermented ("red") tea
The traditional product, and still the bulk of production, is shredded leaves and stems moistened and held at high temperature until they turn red-brown and develop the honey and dried-fruit aroma. Joubert and colleagues compared hot-water extracts of four species before and after this step (Journal of Agricultural and Food Chemistry, 2008). Mangiferin fell by 83% in C. genistoides, 87% in C. sessiliflora, 97% in C. intermedia and 98% in C. subternata; hesperidin fell by 47% to 61%. Extract yield dropped by up to 41% for C. subternata, and total polyphenols in the soluble solids fell from 32.4% to 17.5%. Dudhia and colleagues (Phytomedicine, 2013) measured total polyphenols of 22.4 g gallic acid equivalents per 100 g in unfermented C. maculata extract and 10.8 g in the fermented extract, with mangiferin dominant in the first and hesperidin in the second.
What fermentation does chemically
Despite the name, traditional honeybush "fermentation" is not a microbial process. It is a heat-driven oxidation, and its compound losses follow first-order kinetics. Beelders and colleagues modeled C. genistoides held at 80 and 90 °C (Journal of Agricultural and Food Chemistry, 2015): the benzophenone iriflophenone-3-C-glucoside-4-O-glucoside was the most heat-stable major compound, while mangiferin and iriflophenone-3-C-glucoside degraded at comparable rates at 80 °C, and a 90 °C, 16-hour model accurately predicted three of the four compounds in different batches. In solution, mangiferin breaks down faster as both temperature and pH rise (Beelders and colleagues, Food Research International, 2017). Process control matters for safety too: heap fermentation was associated with mold and bacterial contamination, mainly Rhizomucor pusillus, while rotary-drum processing cut total bacterial counts below 1,000 per gram with no molds, Salmonella or E. coli detected (as reviewed by Joubert and colleagues, 2011).
Green (unfermented) tea
Green honeybush is cut and dried without oxidation, sometimes after a 60-second steam treatment at about 90 to 93 °C to protect color and aroma (Joubert and colleagues, 2010; Alexander and colleagues, 2018). It keeps most of the xanthones, which is why green C. genistoides and C. maculata are the preferred raw materials for extracts. The trade-off is taste: green C. genistoides infusions are bitter enough that a 2018 Food Chemistry study called the taste "unacceptable to consumers," and mangiferin itself was significantly more bitter than isomangiferin at equal concentration (Alexander and colleagues).
Food-ingredient and nutraceutical extracts
Aqueous extracts of green C. subternata are sold to beverage makers. De Beer and colleagues (Molecules, 2012) analyzed hot-water extracts from 64 seedlings of the same age grown together at one farm. Extract yield ran 16.3% to 24.0%, mean mangiferin was 0.9% (relative standard deviation 45%), hesperidin 0.64% (56%), and total polyphenols 26.5%. Leaf extracts held more than twice the mangiferin of stem extracts, while stems held 3.1 times more hesperidin. The authors concluded that seedling-grown material is too variable to standardize on a single compound and proposed total antioxidant capacity or vegetatively propagated plants instead. We found no pharmacopoeial monograph for Cyclopia and no agreed marker percentage, so "standardized honeybush extract" on a label has no shared definition.
HU-018, the only extract tested orally in a trial
Im and colleagues (Evidence-Based Complementary and Alternative Medicine, 2020) describe the process. Honeybush supplied by Rooibos Ltd. of Clanwilliam is extracted twice with water under reflux and concentrated to 20 brix. The concentrate (23% of the mix) is combined with 63.5% water, 3% lactose and 0.5% whole milk powder, inoculated with lactic acid bacteria at 10% of the mix, fermented at 37 °C for 48 hours, sterilized, blended with dextrin and spray-dried. The papers do not state the honeybush content per gram of finished powder or any mangiferin or hesperidin specification. Huons markets HU-018 in Korea as Innerset Honeybush, which received an individual functional-ingredient recognition from the Ministry of Food and Drug Safety for helping skin health against damage caused by ultraviolet light.
Research extracts you cannot buy
SM6Met (C. subternata, sequential methanol extract), P104 (C. genistoides methanol extract), CPEF (a C. intermedia polyphenol-enriched organic fraction) and Cycloferin (a Cyclopia extract tested in diabetic rats at the University of California, Irvine, 2018) each carry their own published results. None is the same as a tea bag, and none has been tested in a human trial.
Food Sources
Honeybush tea is the food. No other plant supplies the Cyclopia mix of compounds, so the useful questions are how much a cup contains and what changes it.
What a cup delivers
A 2015 paper in the Journal of Food Composition and Analysis, titled "Honeybush herbal teas (Cyclopia spp.) contribute to high levels of dietary exposure to xanthones, benzophenones, dihydrochalcones and other bioactive phenolics," measured this directly; we could not access its figures, so here is the arithmetic from figures we could check. Hot water dissolved 16.3% to 24.0% of green C. subternata plant material as solids in a laboratory extraction (de Beer and colleagues, 2012). Unfermented C. genistoides extract solids contain 9.55% mangiferin, so a 2.5 g serving extracted at 20% would give at most about 48 mg. Fermented C. intermedia, the species in most wild-harvested red tea, loses 97% of its mangiferin, which leaves well under 1 mg in the same serving. Those are ceilings, because laboratory extractions run longer and hotter than a mug steeped for 5 minutes.
What changes it
Species: C. genistoides carries roughly three and a half times the mangiferin of C. subternata in unfermented extracts (9.55 versus 2.73 g per 100 g).
Oxidation: fermented tea keeps 2% to 17% of the original mangiferin and 39% to 53% of the hesperidin, depending on species.
Plant part: stems carry more hesperidin and leaves more mangiferin, so sieving out coarse stems shifts the balance.
Water: in a 2025 Journal of Food Science study (van Schoor and colleagues), spring water at pH 8.3 and brackish water with electrical conductivity above 10 mS/m lowered mangiferin and isomangiferin in the cup and produced an atypical "date pudding" aroma; tap, reverse-osmosis and a second spring water performed like deionized water.
Minerals
Malik and colleagues (Food Chemistry, 2008) measured ten elements in 31 samples of tea, coffee and herbal infusions and found honeybush infusions low in all of them except calcium. Honeybush is not a meaningful mineral source.
Other foods with the same compounds
Mangiferin's commercial sources are mango leaves and stem bark, and mango-leaf ethanol and water extracts contain about 7.3% and 1.0% mangiferin, respectively (as cited by de Beer and colleagues, 2012). Hesperidin is the main flavanone of citrus fruit and peel. A buyer who wants hesperidin specifically gets far more of it from citrus than from honeybush.
Who Should Take Honeybush
Honeybush tea suits adults who want a sweet, low-tannin herbal infusion and enjoy the taste. As a beverage it has a long record of ordinary use in South Africa and, since the 1990s, in the Netherlands and Germany.
As a supplement, the only population with trial data is Korean adults with crow's feet wrinkles who took 400 or 800 mg a day of HU-018 for 12 weeks. A buyer interested in skin should know that the result applies to that one lactic-acid-fermented, dextrin-carried product, not to tea or to other honeybush capsules.
No group has evidence-based reason to take honeybush for menopausal symptoms, blood sugar control, weight loss or cancer prevention. Anyone choosing it for those reasons is relying on cell and animal work.
Who Should AVOID or Use Caution
Contraindications
An allergy to honeybush or to any other ingredient in the product. HU-018-based products are made with whole milk powder and lactose, so people with milk allergy should check the finished-product label.
Use as a replacement for prescribed treatment of diabetes, menopausal symptoms or cancer. The supporting evidence is preclinical.
Use Caution
Hormone-sensitive conditions (breast, uterine or ovarian cancer, endometriosis, fibroids). Cyclopia extracts bind estrogen receptors in cell assays, and C. genistoides methanol extracts stimulated proliferation of MCF-7 and MDA-MB-231 breast cancer cells on their own while opposing estradiol-driven growth (Verhoog and colleagues, 2007). A "cup-of-tea" preparation of C. subternata was also active at both estrogen receptors in cells (Visser and colleagues, 2013), so ordinary tea is a smaller exposure, not a proven-inactive one. Growth stimulation in the absence of estradiol is the result most relevant to women whose estrogen is suppressed, such as those on aromatase inhibitors. The net effect in a person is unknown.
Diabetes treated with insulin, sulfonylureas or acarbose. Honeybush extracts lowered glucose in rats and enhanced acarbose's enzyme inhibition in vitro. No human data exist, so check glucose readings if starting a concentrated extract.
Pregnancy and breastfeeding. There are no safety studies. The folk claim that honeybush increases breast milk is anecdotal and untested.
Tamoxifen, letrozole or fulvestrant. Honeybush extracts have been tested alongside these drugs only in cells and rodents, and in laboratory studies mangiferin inhibited liver enzymes, including those tamoxifen needs to become active (see Interactions).
Children. No pediatric data exist for extracts.
Critical Safety Point
The estrogen-receptor activity that makes honeybush interesting to menopause marketers is also the reason a woman with a hormone-sensitive cancer, or on endocrine therapy, should not take concentrated Cyclopia extracts without her oncologist's agreement. The receptor studies show mixed agonist and antagonist effects depending on extract, receptor subtype and cell type, and none has been repeated in humans.
Recommended Dosages
No regulator or pharmacopoeia has set a dose for honeybush, and no dose has been shown to treat any condition.
Tea, loose or bagged
Frontier Co-op's organic honeybush, which lists Cyclopia intermedia as its botanical source and the Republic of South Africa as origin, directs 1 to 3 teaspoons in 8 oz of near-boiling water, steeped 4 to 6 minutes. No authority has published an intake ceiling for the tea.
HU-018 fermented extract
The Korean trial used 400 mg or 800 mg a day for 12 weeks, and the abstract reports improvements against placebo at both doses. Follow the finished product's label, which may express the amount differently from the trial.
Other honeybush capsules and extracts
No human dose has been tested. Without an extraction ratio and a mangiferin or hesperidin figure on the label, the amount of plant material per capsule cannot be worked out.
Duration
The longest controlled exposure in humans is 12 weeks (HU-018). Long-term safety information for the tea comes from customary use, not from studies.
Timing & Administration
There is no evidence that time of day changes any effect. Honeybush contains no caffeine, so evening use poses no sleep problem from stimulants. Brew with near-boiling water of ordinary pH; very alkaline or mineral-heavy water reduces mangiferin in the cup. Mangiferin degrades faster at higher temperature and pH, so prolonged boiling and long storage of brewed tea lose xanthones; in ready-to-drink model solutions stored for 180 days at 25 °C, mangiferin was one of the two most labile compounds (Human and colleagues, Journal of the Science of Food and Agriculture, 2023). Take HU-018 products as labeled; the trial abstract does not specify timing relative to meals.
Timeline of Effects
Absorption
In the one human pharmacokinetic study of isolated mangiferin, plasma levels peaked about 1 hour after an oral dose and the elimination half-life was just under 8 hours (details under How Honeybush Works). No one has measured onset or clearance after drinking honeybush tea or taking a honeybush extract.
Skin
The HU-018 trial measured outcomes at 12 weeks; the abstract does not report earlier time points. The 2-week topical study found smoother skin but no hydration change against placebo.
Glucose, menopause, weight
No human timeline exists because no human trial exists.
A fair test, and the point to quit
For an HU-018 product, 12 weeks at the trial dose matches the only study; no visible change in wrinkles or skin dryness by then means the product is not working for you. For the other marketed uses there is no evidence-based trial period, and blood glucose or menopausal symptoms that are not controlled need medical review, not a longer course of tea.
Benefits of Taking Honeybush
Sorted by the strength of the human evidence:
Skin wrinkles, hydration and elasticity: one company-coauthored randomized trial of one fermented extract (HU-018, 120 participants, 12 weeks) reported improvement against placebo.
Skin smoothness from a 2% topical cream: one 2-week study in 16 women, with no hydration benefit.
A pleasant, low-tannin hot or iced drink: the benefit nobody needs a trial for.
Glucose control, weight, menopausal symptoms, allergy and cancer prevention: animal and cell results only.
Honeybush may still be a reasonable daily tea. As a supplement, everything beyond the HU-018 skin result is a hypothesis.
Potential Negatives & Side Effects
What the human record shows
The HU-018 trial reported no adverse effects over 12 weeks at either dose. A 2007 review by McKay and Blumberg (Phytotherapy Research) stated that no adverse effects of honeybush consumption as a tisane had been reported, and we found no case report of harm attributed to honeybush in PubMed through November 2026. That is an absence of reports, not a safety study.
Mutagenicity signals in laboratory tests
Honeybush is usually described as antimutagenic, and in most Salmonella assays it is. Two results run the other way. Unfermented C. genistoides either protected against or enhanced 2-acetylaminofluorene mutagenicity depending on concentration (van der Merwe and colleagues, Mutation Research, 2006), and liver microsomes from rats that drank unprocessed honeybush for 10 weeks enhanced the mutagenic response to the same chemical (Marnewick and colleagues, Mutation Research, 2004). Neither finding has been linked to any human effect.
Rat sperm
Healthy male Wistar rats given honeybush infusion for 7 weeks showed non-significant decreases of 18.2% in total sperm motility and 20.7% in progressive motility compared with controls, alongside a 31.7% rise in superoxide dismutase activity (Omolaoye and colleagues, Frontiers in Physiology, 2023). The authors suggested the herbal infusions might raise sperm concentration while impairing motility and morphology. This is one rat study with non-significant motility changes.
Taste and formulation issues
Green C. genistoides is markedly bitter. HU-018-based products contain milk-derived ingredients and dextrin, which matter to people avoiding dairy or tracking carbohydrates in very small amounts.
Deficiency Symptoms
What honeybush addresses
Nothing. Honeybush supplies no essential nutrient, and no deficiency state is linked to not drinking it.
Bottom line
Skipping honeybush leaves no gap that a diet without it fails to fill.
Toxicity Symptoms
At high intake
No human toxicity study exists. The HU-018 developers state that they confirmed the extract's nontoxicity in Sprague Dawley rats and beagles before the trial, but the papers we read do not report the doses tested or a no-observed-adverse-effect level. In cell culture, unfermented C. maculata extract at 800 and 1,600 µg/mL and C. subternata at 1,600 µg/mL reduced mitochondrial activity in pre-adipocytes (Dudhia and colleagues, 2013). Those are whole-extract concentrations with no measured human blood equivalent; for scale, plasma mangiferin peaked at 38.64 ng/mL even after 0.9 g of the pure compound. In rats given honeybush as their only drinking fluid for 10 weeks, liver microsomal cytochrome P450 content did not change (Marnewick and colleagues, 2004).
Signs to reduce or stop
On insulin, a sulfonylurea or acarbose: glucose readings below your target, or shakiness and sweating, after starting a concentrated extract.
Milk allergy: hives, swelling or wheezing after an HU-018-based product.
On hormone therapy or with a history of hormone-sensitive cancer: new breast changes or unexpected vaginal bleeding, given the estrogen-receptor findings.
Any digestive upset that begins with a new extract and resolves when it is stopped.
General note
For tea at normal strength, the realistic risks are the ones already listed: an interaction for people on specific drugs and contamination from poor processing. The unknowns grow with concentration, because extracts deliver many times the polyphenol load of a cup and have no human safety data beyond one 12-week trial.
How Honeybush Works
Honeybush's proposed effects are attributed to three compound classes, all present as sugar-bound glycosides that the small intestine absorbs poorly.
Xanthones: mangiferin and isomangiferin
Mangiferin is a xanthone (a three-ring aromatic core) with glucose attached through a carbon-carbon bond at position 2; isomangiferin carries it at position 4. The C-glucosyl bond resists human digestive enzymes, so most mangiferin reaches the colon intact, where bacteria strip the sugar to leave the aglycone norathyriol. Absorption of the intact compound is low. In 21 healthy Chinese men given single oral doses of isolated mangiferin, the highest dose, 0.9 g, produced a plasma peak of only 38.64 ng/mL about 1 hour later, with an elimination half-life of 7.85 hours and nonlinear kinetics (Hou and colleagues, Food Chemistry, 2011). In pigs fed a C. genistoides extract supplying up to 74 mg of mangiferin per kilogram daily for 11 days, only 1.4% to 1.6% of the mangiferin dose appeared in urine; norathyriol was the main form found in plasma (mean 7.8 to 11.8 µmol/L) and feces, and bacterial cleavage products such as 3,4-dihydroxybenzoic acid and gallic acid appeared in feces (Bock and colleagues, Nutrition Research, 2008 and 2010).
Flavanones: hesperidin and its relatives
Hesperidin is hesperetin bound to the disaccharide rutinose through an oxygen bond. Human enzymes in the small intestine do not cleave rutinose efficiently, so most hesperidin is deglycosylated by colonic bacteria before hesperetin is absorbed and conjugated. That route recovers far more than mangiferin's: pigs excreted 26.0% to 30.8% of the hesperidin dose in urine as hesperetin, hesperetin glucuronide and eriodictyol glucuronide. Eriocitrin and narirutin follow the same pattern. In honeybush, hesperidin survives fermentation better than mangiferin, which is why fermented tea is relatively flavanone-rich.
The gut as the likely site of action
Miller and colleagues tested xanthone- and benzophenone-enriched C. genistoides fractions on excised pig jejunum (Planta Medica, 2020). Mangiferin, isomangiferin and two iriflophenone glucosides permeated poorly in the absorptive direction, and the efflux ratio of 3-β-D-glucopyranosyl-4-O-β-D-glucopyranosyliriflophenone (3.05) matched that of rhodamine 123 (2.99), a known P-glycoprotein substrate. The authors argued that low uptake would concentrate these compounds in the gut lumen, where alpha-glucosidase inhibition would matter. In the enzyme assay, mangiferin's IC50 was 102.2 µM against acarbose's 44.3 µM, and combining the two was synergistic, with calculated acarbose dose reductions above sixfold (Miller and colleagues, Food and Function, 2020).
Estrogen receptors
Cyclopia extracts act on both estrogen receptor subtypes, but the compounds responsible are unidentified. Verhoog and colleagues found that the phytoestrogenic activity of C. genistoides extracts "cannot be ascribed to polyphenols known to be present in other Cyclopia species," and when Mortimer and colleagues fractionated SM6Met (PLoS One, 2015), the desirable estrogenic profile separated across fractions instead of concentrating in one. This is the main reason no honeybush product can be standardized for an estrogen-related effect.
Fat tissue and liver enzymes
In db/db mice, the C. intermedia polyphenol-enriched fraction raised uncoupling protein 1 3.4-fold and PPAR-alpha 2.6-fold in brown fat, raised liver PPAR-alpha 2.2-fold and reduced liver fat droplets by 31.9%; docking studies pointed to hesperidin and neoponcirin. In rat livers, honeybush tea raised glutathione S-transferase alpha activity, and the unprocessed tea marginally raised microsomal UDP-glucuronosyltransferase (Marnewick and colleagues, Journal of Agricultural and Food Chemistry, 2003), phase II enzymes the authors linked to protection against mutagenesis.
Synergistic Supplements
Blends that are already common
Honeybush is often blended with rooibos. The two contribute different signature compounds (rooibos its dihydrochalcones, honeybush its xanthones), but no study has tested the blend for a health outcome. Huons Natural, a Huons subsidiary, sells HU-018 in a calamansi drink, pairing it with a vitamin C-rich citrus; that pairing is a product choice, not a tested synergy.
Additives that change stability
In ready-to-drink models built on a green C. subternata extract, ascorbic acid stabilized the labile dihydrochalcone HPDG and citric acid stabilized mangiferin, yet the base solution without either acid was the most stable overall across all major phenolics (Human and colleagues, 2023).
What not to stack
Avoid combining concentrated honeybush extracts with other estrogen-active extracts (red clover, soy isoflavones, hops) while the receptor effects remain uncharacterized in people.
Interactions & What NOT to Take
We found no interaction study of honeybush in humans. The named-drug data below come from cells, enzymes and rodents.
Acarbose
Mangiferin, isomangiferin and xanthone-enriched C. genistoides fractions acted synergistically with acarbose against alpha-glucosidase in vitro. If that held in people, a concentrated extract could add to acarbose's effect on post-meal glucose and its digestive side effects.
Insulin, sulfonylureas and other glucose-lowering drugs
Honeybush extracts lowered fasting glucose in diabetic rats. The combination has not been studied, so treat a concentrated extract as a possible additive effect and monitor glucose.
Tamoxifen
In MCF-7 breast cancer cells, SM6Met combined with 4-hydroxytamoxifen (tamoxifen's active metabolite) was strongly synergistic: a 20 times lower 4-hydroxytamoxifen concentration achieved the same inhibition of proliferation (van Dyk and colleagues, Frontiers in Pharmacology, 2022). That is a laboratory hypothesis about future combination therapy, not a reason to self-combine. Evidence also runs the other way: purified mangiferin inhibited cytochrome P450 activity in rat liver microsomes, and a mangiferin-containing Chinese herbal formula (Baihe Zhimu, not honeybush) lowered blood levels of tamoxifen's active metabolites, endoxifen and 4-hydroxytamoxifen, and weakened its antitumor effect in mice (Li and colleagues, BMC Complementary and Alternative Medicine, 2019). A woman on tamoxifen should not add a Cyclopia extract on her own.
Letrozole and fulvestrant
SM6Met was compared with tamoxifen, letrozole and fulvestrant in a rat mammary tumor model (Oyenihi and colleagues, 2018) and in breast cancer cell lines (Olayoku and colleagues, 2023). These were side-by-side comparisons, not combination safety studies.
Drug-metabolizing enzymes
Rat studies showed raised glutathione S-transferase alpha activity, a marginal rise in UDP-glucuronosyltransferase with unprocessed tea, and no change in microsomal cytochrome P450 content. Enzyme activity is a different question from enzyme content: in cultured human liver cells, mango stem-bark extract and purified mangiferin lowered the activity of CYP1A2, 2A6, 2C9, 2D6 and 3A4, by at least 50% at the highest concentration tested (250 µg/mL), and mangiferin also reduced UGT1A1 and UGT2B7 activity by about 55% (Rodeiro and colleagues, Phytotherapy Research, 2012). That concentration is thousands of times the plasma level measured in people, so the clinical relevance is unknown. Glucuronidation clears drugs such as acetaminophen, lorazepam and mycophenolic acid, but no study has measured whether honeybush changes their levels. Joubert and colleagues (Natural Product Communications, 2009) flagged this enzyme modulation as something that "could affect the therapeutic window of drugs."
Quality, Testing & Adulteration
Blending species is normal practice
Honeybush supply has trailed demand for years, and a 2017 Food Research International paper (Moelich and colleagues) notes that this forces tea merchants to blend whatever material is available, despite distinct flavor differences between species. The 2022 to 2023 industry figures show why a bag labeled only "honeybush" can contain very different plants: the wild crop is mostly C. intermedia, while the cultivated crop is 47% C. subternata, 43% C. longifolia and 10% C. genistoides. Given the three-and-a-half-fold spread in mangiferin between species and the near-total loss in fermented C. intermedia, an unlabeled blend says little about what is in the cup.
Telling the species apart
Authentication is hard even for specialists. Małyjurek and colleagues (Analytica Chimica Acta, 2021) used near-infrared hyperspectral imaging on C. intermedia, C. subternata and C. genistoides: one-class models correctly classified only 76.4% of C. genistoides and 83.1% of C. subternata samples, and a discriminant model reached 98.9% but cannot flag a sample that belongs to none of the classes; the authors' combined two-step method reached 97.4%. Chemical fingerprinting by liquid chromatography and mass spectrometry separates species better (Stander and colleagues, 2019), but we found no routine commercial test for honeybush species identity.
Microbial standards
South African export standards for honeybush require Salmonella to be absent and set limits for total bacteria, coliforms, molds and yeasts; unfermented tea is allowed up to 20 colony-forming units of E. coli per gram and a higher total bacterial count (as reviewed by Joubert and colleagues, 2011). The heap-fermentation contamination problem described under Forms & Standardization is the reason these limits exist.
Errors that travel
The 2020 paper describing HU-018's preclinical work states in its introduction that honeybush "is a rare source of the dietary dihydrochalcones aspalathin and nothofagin." Those are signature compounds of rooibos. In their C. subternata study, de Beer and colleagues (2012) reported that aspalathin "was not observed in any of the extracts analyzed." Similar slips appear in marketing copy, so check any compound list against the primary chemistry papers.
Third-party testing
We found no USP verification program, NSF certification category or ConsumerLab review specific to honeybush. Organic certification, as claimed for Frontier Co-op's tea, covers farming and handling practices, not compound content or species identity. A Nagoya Protocol permit, which Agulhas Honeybush Tea obtained in December 2023 and the ingredient firm Nektium announced in June 2024, documents legal access to the genetic resource, not purity.
What the paperwork should include
For an extract or capsule: the Latin species name or names, wild or cultivated origin, fermented or green material, plant part, extraction solvent and ratio, HPLC results for mangiferin and hesperidin with the method, microbial results including Salmonella, a pesticide screen, and every carrier and allergen (dextrin and milk in HU-018 products). For tea: species, origin and processing type at minimum.
Checks you can run yourself
Read the botanical line. Steenbergs' organic honeybush names Cyclopia intermedia and says it comes "only from wild harvesting, as no commercial plantations exist," while Frontier Co-op's page names C. intermedia but says nothing about wild or farmed origin.
Look at the leaf. Green honeybush keeps a green color; fermented tea is red-brown. If a product sold for mangiferin is red-brown, most of the mangiferin is gone.
Ask the seller of any capsule for its mangiferin percentage and the batch result. No answer means no standardization.
For a skin product citing the Korean trial, confirm it actually contains HU-018.
Special Considerations
The supply picture in numbers
The South African Honeybush Tea Association's statistics report, dated May 2023, describes nine processors, each producing 20 to 200 tonnes a year, with 55 full-time jobs across the processors that responded. Earlier estimates put the wild share higher: an industry review for the Western Cape government (McGregor, March 2017) estimated about 80% of the annual crop as wild, with exports averaging roughly 390 tonnes of processed tea a year over 2010 to 2016 and about 90% of the crop going to the Netherlands, Germany and the United Kingdom. The same review recorded farm-gate prices of R11 per kilogram for wild C. intermedia, against retail prices abroad of about R534 to R1,216 per kilogram. Joubert and colleagues counted only about 200 hectares under cultivation in 2011.
Why wild C. intermedia is vulnerable
C. intermedia resprouts from a woody rootstock after fire but recruits poorly from seed (Galuszynski and colleagues, PeerJ, 2020). The Rhodes University study surveyed 38 sites and found seedlings scarce everywhere, including recently burned ground; unharvested plants produced significantly more seed pods; a cultivated stand cut every three years shrank in every measured dimension over 12 years; and the authors recommended at least four years between harvests. The 2022 Biodiversity Management Plan (Government Gazette 46597, Notice 2192) lists illegal harvesting on communal land, in nature reserves and on farms with absent owners, removal of too much material too often, expansion of farming and settlement, and shading by invasive black wattle and pine. Both C. intermedia and C. subternata remain Least Concern on the Red List despite their decline. Other Cyclopia species are in worse shape: C. pubescens, restricted to the Nelson Mandela Bay area, is Critically Endangered, though it is not used for tea.
Genetic pollution from cultivation
Cultivation can protect wild stands, but it introduces its own risk. Across wild and cultivated populations of three widely grown honeybush species, Galuszynski and colleagues (PeerJ, 2021) found 17 chloroplast haplotypes, of which 13 occurred only in the wild and 4 were shared. Wild populations held significantly more genetic diversity. Planting seed from distant sources next to wild stands of these ant-dispersed, bee-pollinated shrubs can dilute local lineages, which is why the authors call for a "duty of care" in cultivation.
Regulatory status
European Union: "Honeybush Tea" is a protected geographical indication under the 2016 Economic Partnership Agreement. The inventory of herbs considered as food published by Tea and Herbal Infusions Europe (THIE, June 22, 2023) lists C. genistoides, C. intermedia, C. sessiliflora and C. subternata, but not C. maculata. We could not confirm a Cyclopia entry in the European Commission's Novel Food Status Catalogue; honeybush tea was exported to Germany from May 1995, before the regulation's May 15, 1997 reference date, but concentrated extracts are a separate question.
South Korea: HU-018 holds an individual functional-ingredient recognition from the Ministry of Food and Drug Safety for skin health against ultraviolet damage.
United States: sold as a conventional tea and as a dietary supplement ingredient, with no federal review of dose or claims.
Research Status & Evidence Quality
Tier 1, randomized controlled trial (one)
Choi and colleagues, 2018: HU-018, 400 or 800 mg a day for 12 weeks, 120 Korean adults, improvements in wrinkles, hydration, elasticity and transepidermal water loss against placebo. Four of eight authors were from the manufacturer, completers and effect sizes are not in the abstract, and no replication exists.
Tier 2, small controlled topical study (one)
Gerber and colleagues, 2015: 2% C. maculata or C. genistoides creams, 16 women, 2 weeks, better smoothness, no hydration benefit, unstable formulations.
Tier 3, animal studies
Glucose lowering in streptozotocin-diabetic and obese insulin-resistant rats; reduced weight gain and liver fat in db/db mice; inhibition of chemically induced skin and esophageal tumor development in rodents and a marginal reduction in precancerous liver foci; delayed mammary tumors with SM6Met in rats; anti-allergic effects in mice; photoprotection in hairless mice. Doses, extracts and routes vary, and several used fractions or solvents never sold to consumers.
Tier 4, cell and enzyme studies
Alpha-glucosidase inhibition, estrogen receptor subtype activity, adipocyte lipolysis and adipogenesis, antimutagenicity in Salmonella assays, mitochondrial protection in neuroblastoma cells, bone-resorbing osteoclast inhibition, and skin enzyme inhibition.
Research Limitations
Twenty-three species and two processing styles mean that "honeybush" in one study may share little chemistry with "honeybush" in the next.
The most-studied preparations (SM6Met, P104, CPEF, xanthone-enriched fractions) are not commercial products.
Human absorption data exist only for pure mangiferin, not for honeybush tea or extract.
No trial has tested menopausal symptoms, glucose control, body weight or any cancer outcome.
Much of the literature comes from a small network of South African groups (the Agricultural Research Council, the South African Medical Research Council and Stellenbosch University), and the only oral trial came from the product's manufacturer.
A 2025 review (Willemse and colleagues, Chinese Herbal Medicines) found no proteomic or metabolomic study of honeybush health effects.
Summary & Key Takeaways
Bottom Line
Honeybush is a well-characterized herbal tea whose chemistry depends on species and on whether it was oxidized: unfermented C. genistoides is rich in mangiferin, while red C. intermedia, the commonest wild-harvested tea, retains very little. The menopause, blood sugar and weight claims rest on rodents and cell cultures. The one oral trial supports a single Korean lactic-fermented extract for skin wrinkles and hydration and says nothing about tea.
Key Safety Points
No adverse effects were reported in the only trial, and no case reports of harm surfaced in our search, but extracts have no human safety data beyond 12 weeks.
Women with hormone-sensitive cancers or on tamoxifen, letrozole or fulvestrant should avoid concentrated Cyclopia extracts unless their oncologist agrees.
People on acarbose, insulin or sulfonylureas should monitor glucose if they start an extract.
HU-018 is made with milk powder, lactose and dextrin.
No pregnancy, breastfeeding or pediatric safety data exist for extracts.
Special Note
If you buy honeybush, buy it as tea you enjoy, and favor sellers who name the species and say how it was grown or gathered. Cultivated C. subternata or C. genistoides takes pressure off wild mountain stands, and green tea from those species keeps the compounds the research is about.
Forwarded this, or reading it on the web? to get the next breakdown.
Researched and drafted with AI assistance. Every claim verified against primary sources and human-reviewed before publication. Last reviewed: November 7, 2026. Corrections: reply to any issue.
This issue is for education and is not medical advice. If you take prescription medicine, have a diagnosed condition, or are pregnant or breastfeeding, talk to a clinician before taking honeybush extracts or changing anything you already take.
Is Honeybush safe? Common questions
Is Honeybush safe for everyone?
Who may consider it: Honeybush tea suits adults who want a sweet, low-tannin herbal infusion and enjoy the taste. As a beverage it has a long record of ordinary use in South Africa and, since the 1990s, in the Netherlands and Germany. As a supplement, the only… Who should avoid it: Contraindications An allergy to honeybush or to any other ingredient in the product. HU-018-based products are made with whole milk powder and lactose, so people with milk allergy should check the finished-product…
What are possible side effects of Honeybush?
What the human record shows The HU-018 trial reported no adverse effects over 12 weeks at either dose. A 2007 review by McKay and Blumberg (Phytotherapy Research) stated that no adverse effects of honeybush consumption as a tisane had been reported, and we found no case report of harm attributed to honeybush in PubMed through November 2026. That is an…
Does Honeybush interact with medications or other supplements?
We found no interaction study of honeybush in humans. The named-drug data below come from cells, enzymes and rodents. Acarbose Mangiferin, isomangiferin and xanthone-enriched C. genistoides fractions acted synergistically with acarbose against alpha-glucosidase in vitro. If that held in people, a concentrated extract could add to acarbose's effect on…
The Nutrient Wise app checks Honeybush against the medications you take and warns you before you scan a supplement that could interact. It is free to start (5 scans a month, no card): App Store · Google Play.
Medical disclaimer: This page is informational, not medical advice. Talk to a licensed healthcare provider before starting any supplement, especially if you take medications or have a chronic condition. See our privacy policy for how we handle your data inside the app.